324 related articles for article (PubMed ID: 29653075)
1. Inhibition of semicarbazide-sensitive amine oxidase reduces atherosclerosis in apolipoprotein E-deficient mice.
Wang SH; Yu TY; Tsai FC; Weston CJ; Lin MS; Hung CS; Kao HL; Li YI; Solé M; Unzeta M; Chen YL; Chuang LM; Li HY
Transl Res; 2018 Jul; 197():12-31. PubMed ID: 29653075
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Semicarbazide-sensitive Amine Oxidase Reduces Atherosclerosis in Cholesterol-fed New Zealand White Rabbits.
Wang SH; Yu TY; Hung CS; Yang CY; Lin MS; Su CY; Chen YL; Kao HL; Chuang LM; Tsai FC; Li HY
Sci Rep; 2018 Jun; 8(1):9249. PubMed ID: 29915377
[TBL] [Abstract][Full Text] [Related]
3. Effects of an anti-inflammatory VAP-1/SSAO inhibitor, PXS-4728A, on pulmonary neutrophil migration.
Schilter HC; Collison A; Russo RC; Foot JS; Yow TT; Vieira AT; Tavares LD; Mattes J; Teixeira MM; Jarolimek W
Respir Res; 2015 Mar; 16(1):42. PubMed ID: 25889951
[TBL] [Abstract][Full Text] [Related]
4. Inactivation of semicarbazide-sensitive amine oxidase induces the phenotypic switch of smooth muscle cells and aggravates the development of atherosclerotic lesions.
Zhang M; Liu L; Zhi F; Niu P; Yang M; Zhu X; Diao Y; Li Y; Wang J; Zhao Y
Atherosclerosis; 2016 Jun; 249():76-82. PubMed ID: 27065245
[TBL] [Abstract][Full Text] [Related]
5. The inhibitor of semicarbazide-sensitive amine oxidase, PXS-4728A, ameliorates key features of chronic obstructive pulmonary disease in a mouse model.
Jarnicki AG; Schilter H; Liu G; Wheeldon K; Essilfie AT; Foot JS; Yow TT; Jarolimek W; Hansbro PM
Br J Pharmacol; 2016 Nov; 173(22):3161-3175. PubMed ID: 27495192
[TBL] [Abstract][Full Text] [Related]
6. Semicarbazide-sensitive amine oxidase inhibition ameliorates albuminuria and glomerulosclerosis but does not improve tubulointerstitial fibrosis in diabetic nephropathy.
Wong MY; Saad S; Wong MG; Stangenberg S; Jarolimek W; Schilter H; Zaky A; Gill A; Pollock C
PLoS One; 2020; 15(6):e0234617. PubMed ID: 32555665
[TBL] [Abstract][Full Text] [Related]
7. Anti-inflammatory effects of LJP 1586 [Z-3-fluoro-2-(4-methoxybenzyl)allylamine hydrochloride], an amine-based inhibitor of semicarbazide-sensitive amine oxidase activity.
O'Rourke AM; Wang EY; Miller A; Podar EM; Scheyhing K; Huang L; Kessler C; Gao H; Ton-Nu HT; Macdonald MT; Jones DS; Linnik MD
J Pharmacol Exp Ther; 2008 Feb; 324(2):867-75. PubMed ID: 17993604
[TBL] [Abstract][Full Text] [Related]
8. Physiological and pathological implications of semicarbazide-sensitive amine oxidase.
Yu PH; Wright S; Fan EH; Lun ZR; Gubisne-Harberle D
Biochim Biophys Acta; 2003 Apr; 1647(1-2):193-9. PubMed ID: 12686132
[TBL] [Abstract][Full Text] [Related]
9. Inactivation of Semicarbazide-Sensitive Amine Oxidase Stabilizes the Established Atherosclerotic Lesions via Inducing the Phenotypic Switch of Smooth Muscle Cells.
Peng Y; Wang J; Zhang M; Niu P; Yang M; Yang Y; Zhao Y
PLoS One; 2016; 11(4):e0152758. PubMed ID: 27043821
[TBL] [Abstract][Full Text] [Related]
10. Glitazones inhibit human monoamine oxidase but their anti-inflammatory actions are not mediated by VAP-1/semicarbazide-sensitive amine oxidase inhibition.
Carpéné C; Bizou M; Tréguer K; Hasnaoui M; Grès S
J Physiol Biochem; 2015 Sep; 71(3):487-96. PubMed ID: 25572340
[TBL] [Abstract][Full Text] [Related]
11. Anti-inflammatory effects of inhibiting the amine oxidase activity of semicarbazide-sensitive amine oxidase.
Salter-Cid LM; Wang E; O'Rourke AM; Miller A; Gao H; Huang L; Garcia A; Linnik MD
J Pharmacol Exp Ther; 2005 Nov; 315(2):553-62. PubMed ID: 16081681
[TBL] [Abstract][Full Text] [Related]
12. Soluble Vascular Adhesion Protein-1 Mediates Spermine Oxidation as Semicarbazide-Sensitive Amine Oxidase: Possible Role in Proliferative Diabetic Retinopathy.
Murata M; Noda K; Kawasaki A; Yoshida S; Dong Y; Saito M; Dong Z; Ando R; Mori S; Saito W; Kanda A; Ishida S
Curr Eye Res; 2017 Dec; 42(12):1674-1683. PubMed ID: 28937866
[TBL] [Abstract][Full Text] [Related]
13. Involvement of SSAO/VAP-1 in oxygen-glucose deprivation-mediated damage using the endothelial hSSAO/VAP-1-expressing cells as experimental model of cerebral ischemia.
Sun P; Solé M; Unzeta M
Cerebrovasc Dis; 2014; 37(3):171-80. PubMed ID: 24503888
[TBL] [Abstract][Full Text] [Related]
14. Simvastatin blocks soluble SSAO/VAP-1 release in experimental models of cerebral ischemia: Possible benefits for stroke-induced inflammation control.
Sun P; Hernandez-Guillamón M; Campos-Martorell M; Simats A; Montaner J; Unzeta M; Solé M
Biochim Biophys Acta Mol Basis Dis; 2018 Feb; 1864(2):542-553. PubMed ID: 29175057
[TBL] [Abstract][Full Text] [Related]
15. Semicarbazide-sensitive amine oxidase (SSAO) inhibition ameliorates kidney fibrosis in a unilateral ureteral obstruction murine model.
Wong M; Saad S; Zhang J; Gross S; Jarolimek W; Schilter H; Chen JA; Gill AJ; Pollock CA; Wong MG
Am J Physiol Renal Physiol; 2014 Oct; 307(8):F908-16. PubMed ID: 25143459
[TBL] [Abstract][Full Text] [Related]
16. SSAO inhibitors suppress hepatocellular tumor growth in mice.
Li R; Li H; Luo HJ; Lin ZX; Jiang ZW; Luo WH
Cell Immunol; 2013; 283(1-2):61-9. PubMed ID: 23850964
[TBL] [Abstract][Full Text] [Related]
17. Synthetic liver X receptor agonist T0901317 inhibits semicarbazide-sensitive amine oxidase gene expression and activity in apolipoprotein E knockout mice.
Dai X; Ou X; Hao X; Cao D; Tang Y; Hu Y; Li X; Tang C
Acta Biochim Biophys Sin (Shanghai); 2008 Mar; 40(3):261-8. PubMed ID: 18330481
[TBL] [Abstract][Full Text] [Related]
18. Acrolein generation stimulates hypercontraction in isolated human blood vessels.
Conklin DJ; Bhatnagar A; Cowley HR; Johnson GH; Wiechmann RJ; Sayre LM; Trent MB; Boor PJ
Toxicol Appl Pharmacol; 2006 Dec; 217(3):277-88. PubMed ID: 17095030
[TBL] [Abstract][Full Text] [Related]
19. Vascular cell lines expressing SSAO/VAP-1: a new experimental tool to study its involvement in vascular diseases.
Solé M; Unzeta M
Biol Cell; 2011 Nov; 103(11):543-57. PubMed ID: 21819380
[TBL] [Abstract][Full Text] [Related]
20. The inhibition of semicarbazide-sensitive amine oxidase by aminohexoses.
O'Sullivan J; O'Sullivan M; Tipton KF; Unzeta M; Del Mar Hernandez M; Davey GP
Biochim Biophys Acta; 2003 Apr; 1647(1-2):367-71. PubMed ID: 12686159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
